1. P-281The impact of primary tumor location in patients with resected colorectal liver metastasis. (20th June 2018) Authors: Pacheco-Barcia, V; Donnay, O; Solís, R Mondéjar; Serrano, R; Martin, E; del Campo, L; Rogado, J; Vera, B; Ballesteros, A; Colomer, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-281The impact of primary tumor location in patients with resected colorectal liver metastasis. (20th June 2018) Authors: Pacheco-Barcia, V; Donnay, O; Solís, R Mondéjar; Serrano, R; Martin, E; del Campo, L; Rogado, J; Vera, B; Ballesteros, A; Colomer, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P437 Early therapeutic drug monitoring of Adalimumab, but not HLADQ*A1 determination, predicts inflammatory bowel disease outcome. (30th January 2023) Authors: Carrillo Palau, M; Alonso-Abreu, I; Morant, A; Vera, B; Vela, M; Ramos, L; Franco, A; Reygosa, C; Barrios, Y; Medina Chico, J S; Globio, V; Hernández-Perez, A; Jiménez, A; Hernández-Guerra, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗